2018 American Transplant Congress
C1q-Binding Donor-Specific Anti-HLA Antibodies for Clinical Decision Making in Kidney Recipients with Antibody-Mediated Rejection Receiving Standard of Care Treatment
One of the major issues in the clinical management of kidney recipients with ABMR is the lack of early and reliable markers that surrogate long-term…2018 American Transplant Congress
Liver Transplantation in Patients with Spontaneous Spleno-Renal Shunt
Aim: Our aim was to describe the outcomes of liver transplantation (LT) in patients with spontaneous spleno-renal shunt (SSRS) and to define the adequate portal…2018 American Transplant Congress
Living Donor Renal Transplantation in Adult Renal Transplant Recipients Varies Markedly across UNOS Networks
Background: Outcome after living donor kidney transplantation (LD) is significantly better than after deceased donor transplantation (DD). Disparities in access to living donor renal transplantation…2018 American Transplant Congress
What Threshold MFI is the Luminex 1:8 Dilution the Poor Man's C1q for Patients Awaiting Heart Transplant?
Cedars Sinai Medical Center, Los Angeles.
Purpose: Heart transplant candidates are evaluated for anti-HLA antibodies by Luminex single-antigen bead testing to avoid donors that may harbor antigens that these antibodies are…2018 American Transplant Congress
Kidney Transplant Outcome in the Patients with Lupus Nephritis
Background: Despite improvements in overall prognosis in lupus nephritis, 10%-30% of patients with proliferative renal involvement progress to end stage renal disease, and kidney transplantation…2018 American Transplant Congress
Treatment Patterns and Burden among Chronic Graft versus Host Disease Patients on Second-Line Systemic Treatments Including Extracorporeal Photopheresis
Extracorporeal Photopheresis (ECP) is a cell-based immunomodulatory therapeutic procedure reimbursable by the Centers for Medicare and Medicaid Services for patients with chronic Graft versus Host…2018 American Transplant Congress
Enhanced Recovery after Kidney Transplantation Regardless of Donor Organ Source
BACKGROUND: Enhanced recovery after kidney transplantation is a desired outcome with potential value-enhancing benefits of reduced length of stay (LOS), costs, and risk of nosocomial…2018 American Transplant Congress
Reliability of Bronchiolitis Obliterans Syndrome Reporting to the OPTN
Background: Chronic rejection of the lung allograft is traditionally classified as bronchiolitis obliterans syndrome (BOS) diagnosed by obstructive airway physiology. The OPTN requires the reporting…2018 American Transplant Congress
Equivalent Clinical Outcomes and Stable Post-Operative Anti-A IgG Titers in A2 to B Renal Transplant Recipients Compared to Matched B to B Cohort
With the longest wait times and lowest rate of transplantation, ABO type B renal transplant candidates are at a disadvantage when compared to their type…2018 American Transplant Congress
New SLK Allocation Policy May Impact Transplant Outcomes in Women
Background: Previous SLK allocation was based on serum creatinine(Cr), a metric that disadvantaged women(W) relative to men(M). A SLK policy change utilizes eGFR, which accounts…
- « Previous Page
- 1
- …
- 89
- 90
- 91
- 92
- 93
- …
- 155
- Next Page »